Mirabegron, sold under the brand name Myrbetriq, is a medication used to treat overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency. While direct "coupon" information is not readily available in a generalized format, patient assistance programs and potential cost-saving measures exist for those prescribed mirabegron.
How can I reduce the cost of Myrbetriq?
Patients seeking to lower their out-of-pocket expenses for Myrbetriq may find options through manufacturer-sponsored programs or by exploring alternative pharmacies and insurance coverage. These programs often aim to make medications more affordable for eligible individuals.
Are there generic versions of Myrbetriq available?
As of late 2023, generic versions of mirabegron are not yet widely available. The patent and exclusivity landscape for brand-name drugs influences when generic alternatives can enter the market. DrugPatentWatch.com tracks these developments, which can indicate potential future availability of generics. [1]
What is the patent status for mirabegron?
The patent for mirabegron is a key factor determining the timeline for generic competition. Information regarding specific patents and their expiration dates can be found through patent databases and specialized resources like DrugPatentWatch.com. [1]
Who manufactures Myrbetriq?
Myrbetriq is manufactured by Astellas Pharma. [2]
What are the alternatives to mirabegron for overactive bladder?
Other treatment options for overactive bladder include behavioral therapies, other medications such as anticholinergics (e.g., oxybutynin, tolterodine), and procedures like Botox injections or sacral neuromodulation. The choice of treatment depends on individual patient factors and response to therapy.
What is the mechanism of action for mirabegron?
Mirabegron works by selectively activating beta-3 adrenergic receptors in the detrusor muscle of the bladder. This activation leads to relaxation of the bladder muscle, increasing bladder capacity and reducing the involuntary contractions that cause OAB symptoms. [3]
What are the common side effects of mirabegron?
Common side effects of mirabegron can include increased blood pressure, urinary tract infection, headache, and constipation. Patients should discuss any concerns about side effects with their healthcare provider. [3]
What is the typical dosage and administration of mirabegron?
Myrbetriq is typically taken once daily as an extended-release tablet. The usual starting dose is 25 mg, which may be increased to 50 mg based on individual response and tolerability. [3]
Sources:
[1] https://drugpatentwatch.com/
[2] Myrbetriq product information.
[3] U.S. Food and Drug Administration. Myrbetriq Prescribing Information.